ウィメンズヘルスの世界市場規模調査・予測：用途別（閉経後骨粗鬆症、ホルモン性不妊症、子宮内膜症・子宮筋腫、避妊、更年期、多嚢胞性卵巣症候群）、年齢別、地域別分析、2022-2029年

世界のウィメンズヘルス市場は、2021年に約381億1,000万米ドルと評価され、予測期間2022-2029年には4.8%以上の健全な成長率で成長すると予測されています。

ウィメンズヘルスとは、この集団に影響を及ぼす様々な障害を治療するために使用される処置、薬物、手術補助を指します。泌尿器科、栄養学、腫瘍学、生殖学、更年期障害、その他の医療専門分野もすべて対象となります。女性の全般的な健康増進と疾病管理の改善は、ウィメンズヘルスの2大目標です。ウィメンズヘルスに対する国民の意識を高めるために、多数の政府による取り組みが強化されています。世界保健機関（WHO）や米国食品医薬品局（FDA）のようないくつかの組織は、ウィメンズヘルスを向上させるために新しい安全性の取り組みを導入しています。さらに、女性の慢性的な健康状態の発生率の上昇、女性の老年人口の増加、ウィメンズヘルスのための新製品の導入の増加は、市場の成長を促進する主要な要因となっています。

長年にわたり、女性の慢性疾患の指標は、世界のウィメンズヘルス市場の成長に寄与しています。例えば、オーストラリア統計局の推計によると、2021年時点で、オーストラリアでは女性の約半数（49.0%）が1つ以上の慢性疾患を抱えており、5人に1人（20.7%）が2つ以上抱えています。また、国際がん研究機関によると、アジア太平洋地域では、2020年に101万人の乳がん患者が報告され、この数は2025年には111万人、2030年にはさらに120万人に増加すると予測されています。また、公的資金による避妊サービスや製品に対するアンメットニーズの高まり、新興経済諸国におけるヘルスケアインフラの整備は、予測期間中、同市場に有利な成長見通しをもたらすでしょう。しかし、避妊に対する消極的な姿勢は、2022-2029年の予測期間を通じて市場成長の妨げとなります。

ウィメンズヘルスの世界市場調査において考慮した主要地域は、アジア太平洋地域、北米、欧州、ラテンアメリカ、その他の地域です。北米は、ブランド製品の優位性、製品の早期承認・商業化、有利な償還政策、政府規制の支持により、収益面で市場を独占しています。一方、アジア太平洋地域は、予測期間中に最も高いCAGRで成長すると予想されています。これは、老年人口やターゲット人口の増加、女性人口の健康意識を高めるための政府の取り組みの増加などの要因により、予測期間中に市場に有利な成長機会をもたらすと考えられます。

市場における最近の動向

• 2021年5月-ProbiはTervisetehnoloogiate Arenduskeskusと協力し、膣の健康のためのプロバイオティック乳酸菌株をベースにした新規製品を開発する研究開発契約を締結しました。
• 2021年5月、パートナーズグループはアクシア・ウィメンズ・ヘルスを買収しました。この買収は、需要のある付帯サービスの拡大、患者の経験、成果、エンゲージメントの改善、地理的なフットプリントの拡大を目的としています。

世界市場レポートの範囲

• 過去データ：2019-2020-2021年
• 推計の基準年：2021年
• 予測期間：2022-2029年
• レポート範囲：収益予測、企業ランキング、競合情勢、成長要因、動向
• 地域別範囲：北米、欧州、アジア太平洋地域、ラテンアメリカ、世界のその他地域
• カスタマイズの範囲：レポートカスタマイズ（最大8名分の作業時間）を無料で提供。国別、地域別、セグメント別範囲の追加・変更。

本調査の目的は、近年における様々な分野・国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国の産業の質的・量的な側面を取り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢などの詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

• マーケットスナップショット
• 世界・セグメント別市場推定・予測、2019年～2029年
  • ウィメンズヘルス市場、地域別、2019-2029年
  • ウィメンズヘルス市場、用途別、2019-2029年
  • ウィメンズヘルス市場、年齢別、2019-2029年
• 主な動向
• 調査手法
• 調査の前提条件

第2章 ウィメンズヘルスの世界市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 調査対象範囲
  • 産業の進化
• 本調査の対象となった年
• 通貨換算レート

第3章 ウィメンズヘルスの世界市場力学

• ウィメンズヘルス市場のインパクト分析（2019-2029年）
  • 市場促進要因
    • 女性における慢性的な健康状態の発生率の上昇
    • 女性の老年人口の増加
    • ウィメンズヘルス向け新製品の導入が進む
  • 市場の課題
    • 避妊に抵抗がある
  • マーケットオポチュニティ
    • 公的資金別避妊サービスや製品へのアンメットニーズの高まり
    • 新興経済諸国におけるヘルスケアインフラの成長

第4章 世界のウィメンズヘルス市場の産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
• PEST分析
  • 政治的
  • 経済的
  • ソーシャル
  • テクニカル
• 最高の投資機会
• 主要成功戦略
• 業界関係者見通し
• アナリストの提言と結論

第5章 リスクアセスメント：COVID-19の影響

• COVID-19が業界に与える全体的な影響についての評価
• COVID-19以前とCOVID-19以後の市場シナリオ

第6章 ウィメンズヘルスの世界市場：用途別

• マーケットスナップショット
• ウィメンズヘルスの世界市場：用途別、パフォーマンス別- ポテンシャル分析
• ウィメンズヘルスの世界市場推定・予測（用途別） 2019-2029
• ウィメンズヘルス市場、サブセグメント分析
  • 閉経後骨粗鬆症
  • ホルモン性不妊症
  • 子宮内膜症・子宮筋腫
  • 避妊
  • 更年期
  • 多嚢胞性卵巣症候群（PCOS）

第7章 ウィメンズヘルスの世界市場：年齢別

• マーケットスナップショット
• ウィメンズヘルスの世界市場：年齢別、性能別）-ポテンシャル分析
• 世界のウィメンズヘルス市場の年齢別推定・予測2019-2029
• ウィメンズヘルス市場、サブセグメント分析
  • 50歳以上
  • その他

第8章 ウィメンズヘルスの世界市場：地域別分析

• ウィメンズヘルス市場、地域別市場スナップショット
• 北米
  • 米国
    • 用途別の推定・予測、2019年～2029年
    • 年齢別の推定・予測、2019年～2029年
  • カナダ
• 欧州のウィメンズヘルス市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋のウィメンズヘルス市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカのウィメンズヘルス市場スナップショット
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ地域
• 世界のその他の地域

第9章 競合情報

• トップ市場戦略
• 企業プロファイル
  • Pfizer Inc.
    • 主要な情報
    • 概要
    • 財務（データの入手が可能な場合のみ）
    • 製品概要
    • 最近の動向
  • Novartis AG
  • Ferring Pharmaceuticals
  • Apothecus Pharmaceutical
  • Agile Therapeutics Inc.
  • AstraZeneca plc
  • Merck & Co
  • Teva Pharmaceutical Industries
  • LUPIN Limited
  • Eli Lilly and Company

第10章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • バリデーション
  • 出版
• 調査対象者の特徴
• 調査の前提条件

LIST OF TABLES

• TABLE 1. Global Women's Health Market, report scope
• TABLE 2. Global Women's Health Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Women's Health Market estimates & forecasts by Application 2019-2029 (USD Billion)
• TABLE 4. Global Women's Health Market estimates & forecasts by Age 2019-2029 (USD Billion)
• TABLE 5. Global Women's Health Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global Women's Health Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Women's Health Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Women's Health Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Women's Health Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Women's Health Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Women's Health Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Women's Health Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Women's Health Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Women's Health Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. U.S. Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. Canada Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 19. Canada Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. Canada Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. UK Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 22. UK Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. UK Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. Germany Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 25. Germany Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. Germany Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. France Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 28. France Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. France Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. Italy Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 31. Italy Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Italy Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Spain Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 34. Spain Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. Spain Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. RoE Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 37. RoE Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. RoE Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. China Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 40. China Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. China Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. India Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 43. India Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. India Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. Japan Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 46. Japan Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. Japan Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. South Korea Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 49. South Korea Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. South Korea Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. Australia Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 52. Australia Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. Australia Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. RoAPAC Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. Brazil Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 58. Brazil Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Brazil Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Mexico Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 61. Mexico Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. Mexico Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. RoLA Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 64. RoLA Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. RoLA Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. Row Women's Health Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 67. Row Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. Row Women's Health Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. List of secondary sources, used in the study of global Women's Health Market
• TABLE 70. List of primary sources, used in the study of global Women's Health Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Women's Health Market, research methodology
• FIG 2. Global Women's Health Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Women's Health Market, key trends 2021
• FIG 5. Global Women's Health Market, growth prospects 2022-2029
• FIG 6. Global Women's Health Market, porters 5 force model
• FIG 7. Global Women's Health Market, pest analysis
• FIG 8. Global Women's Health Market, value chain analysis
• FIG 9. Global Women's Health Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Women's Health Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Women's Health Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Women's Health Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Women's Health Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Women's Health Market, regional snapshot 2019 & 2029
• FIG 15. North America Women's Health Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Women's Health Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Women's Health Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Women's Health Market 2019 & 2029 (USD Billion)
• FIG 19. Global Women's Health Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Women's Health Market is valued approximately USD 38.11 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.8 % over the forecast period 2022-2029. Women's health refers to the procedures, medications, and surgical aids used to treat the various disorders that affect this population. Urology, nutrition, oncology, reproduction, menopause, and other medical specialties are all covered. Enhancing women's general health and improving illness management are the two main objectives of women's health. The efforts of numerous governments to increase public awareness of women's health are intensifying. Several organizations, such as the World Health Organization (WHO) and the US Food and Drug Administration (FDA), are introducing new safety initiatives to improve women's health. Moreover, rise in incidence of chronic health conditions among women and increasing women geriatric population as well as growing introduction of new products for women's health are key factors driving the market growth.

Over the years the indices of chronic diseases in women are contributing towards the growth of the Global Women's Health Market. For instance- as per Australian Bureau of Statics estimates - as of 2021, Almost half of all females in Australia (49.0%) had one or more chronic conditions, with one in five (20.7%) having two or more. Additionally, as per International Agency for Research on Cancer - In Asia Pacific region around 1.01 million cases of breast cancer reported in 2020, and this number is projected to grow to 1.11 million in 2025, and further 1.20 million in 2030. Also, rising unmet need for publicly funded contraceptive services and products as well as growing healthcare infrastructure in developing economies would create lucrative growth prospectus for the market over the projected period. However, reluctance to Use Contraceptives hinders the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Women's Health Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and early approval & commercialization of products, favorable reimbursement policies, supportive government regulations in the region. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and increasing number of government initiatives for increasing health awareness among female population in the region would create lucrative growth opportunities for the market over the projected period.

Major market players included in this report are:

• Pfizer Inc.
• Novartis AG
• Ferring Pharmaceuticals
• Apothecus Pharmaceutical
• Agile Therapeutics Inc.
• AstraZeneca plc
• Merck & Co
• Teva Pharmaceutical Industries
• LUPIN Limited
• Eli Lilly and Company

Recent Developments in the Market:

• In May 2021 - Probi collaborated with Tervisetehnoloogiate Arenduskeskus and signed a research and development agreement to develop novel products based on probiotic lactobacilli strains for vaginal health.
• In May 2021, Partners Group acquired Axia Women's Health. This acquisition is aimed at expanding in-demand ancillary services, improving patient experience, outcomes and engagement, and expanding its geographical footprint.

Global Women's Health Market Report Scope:

• Historical Data: 2019-2020-2021

• Base Year for Estimation: 2021

• Forecast period: 2022-2029

• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

• Segments Covered: Application, Age, Region

• Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application

Postmenopausal Osteoporosis

Hormonal Infertility

Endometriosis & Uterine Fibroids

Contraceptives

Menopause

Polycystic Ovary Syndrome (PCOS)

By Age

• 50 Years & above
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Women's Health Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Women's Health Market, by Application, 2019-2029 (USD Billion)
  • 1.2.3. Women's Health Market, by Age, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Women's Health Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Women's Health Market Dynamics

• 3.1. Women's Health Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rise in incidence of chronic health conditions among women
    • 3.1.1.2. Increasing women geriatric population
    • 3.1.1.3. Growing introduction of new products for women's health
  • 3.1.2. Market Challenges
    • 3.1.2.1. Reluctance to Use Contraceptives
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising unmet need for publicly funded contraceptive services and products.
    • 3.1.3.2. Growing healthcare infrastructure in developing economies

Chapter 4. Global Women's Health Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Women's Health Market, by Application

• 6.1. Market Snapshot
• 6.2. Global Women's Health Market by Application, Performance - Potential Analysis
• 6.3. Global Women's Health Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
• 6.4. Women's Health Market, Sub Segment Analysis
  • 6.4.1. Postmenopausal Osteoporosis
  • 6.4.2. Hormonal Infertility
  • 6.4.3. Endometriosis & Uterine Fibroids
  • 6.4.4. Contraceptives
  • 6.4.5. Menopause
  • 6.4.6. Polycystic Ovary Syndrome (PCOS)

Chapter 7. Global Women's Health Market, by Age

• 7.1. Market Snapshot
• 7.2. Global Women's Health Market by Age, Performance - Potential Analysis
• 7.3. Global Women's Health Market Estimates & Forecasts by Age 2019-2029 (USD Billion)
• 7.4. Women's Health Market, Sub Segment Analysis
  • 7.4.1. 50 Years and Above
  • 7.4.2. others

Chapter 8. Global Women's Health Market, Regional Analysis

• 8.1. Women's Health Market, Regional Market Snapshot
• 8.2. North America Women's Health Market
  • 8.2.1. U.S. Women's Health Market
    • 8.2.1.1. Application breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. Age breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada Women's Health Market
• 8.3. Europe Women's Health Market Snapshot
  • 8.3.1. U.K. Women's Health Market
  • 8.3.2. Germany Women's Health Market
  • 8.3.3. France Women's Health Market
  • 8.3.4. Spain Women's Health Market
  • 8.3.5. Italy Women's Health Market
  • 8.3.6. Rest of Europe Women's Health Market
• 8.4. Asia-Pacific Women's Health Market Snapshot
  • 8.4.1. China Women's Health Market
  • 8.4.2. India Women's Health Market
  • 8.4.3. Japan Women's Health Market
  • 8.4.4. Australia Women's Health Market
  • 8.4.5. South Korea Women's Health Market
  • 8.4.6. Rest of Asia Pacific Women's Health Market
• 8.5. Latin America Women's Health Market Snapshot
  • 8.5.1. Brazil Women's Health Market
  • 8.5.2. Mexico Women's Health Market
  • 8.5.3. Rest of Latin America Women's Health Market
• 8.6. Rest of The World Women's Health Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Pfizer Inc.
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Novartis AG
  • 9.2.3. Ferring Pharmaceuticals
  • 9.2.4. Apothecus Pharmaceutical
  • 9.2.5. Agile Therapeutics Inc.
  • 9.2.6. AstraZeneca plc
  • 9.2.7. Merck & Co
  • 9.2.8. Teva Pharmaceutical Industries
  • 9.2.9. LUPIN Limited
  • 9.2.10. Eli Lilly and Company

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption